Literature DB >> 20693693

Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase.

Mikko Salin1, Evangelia G Kapetaniou, Matti Vaismaa, Marja Lajunen, Marco G Casteleijn, Peter Neubauer, Laurent Salmon, Rik K Wierenga.   

Abstract

Crystallographic binding studies have been carried out to probe the active-site binding properties of a monomeric variant (A-TIM) of triosephosphate isomerase (TIM). These binding studies are part of a structure-based directed-evolution project aimed towards changing the substrate specificity of monomeric TIM and are therefore aimed at finding binders which are substrate-like molecules. A-TIM has a modified more extended binding pocket between loop-7 and loop-8 compared with wild-type TIM. The A-TIM crystals were grown in the presence of citrate, which is bound in the active site of each of the two molecules in the asymmetric unit. In this complex, the active-site loops loop-6 and loop-7 adopt the closed conformation, similar to that observed in liganded wild-type TIM. Extensive crystal-soaking protocols have been developed to flush the bound citrate out of the active-site pocket of both molecules and the crystal structure shows that the unliganded open conformation of the A-TIM active site is the same as in unliganded wild-type TIM. It is also shown that sulfonate compounds corresponding to the transition-state analogue 2-phosphoglycolate bind in the active site, which has a closed conformation. It is also shown that the new binding pocket of A-TIM can bind 3-phosphoglycerate (3PGA; an analogue of a C4-sugar phosphate) and 4-phospho-D-erythronohydroxamic acid (4PEH; an analogue of a C5-sugar phosphate). Therefore, these studies have provided a rationale for starting directed-evolution experiments aimed at generating the catalytic properties of a C5-sugar phosphate isomerase on the A-TIM framework.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693693     DOI: 10.1107/S0907444910025710

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  5 in total

1.  Crystal structures of two monomeric triosephosphate isomerase variants identified via a directed-evolution protocol selecting for L-arabinose isomerase activity.

Authors:  Mirja Krause; Tiila Riikka Kiema; Peter Neubauer; Rik K Wierenga
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-05-23       Impact factor: 1.056

2.  Wildtype and engineered monomeric triosephosphate isomerase from Trypanosoma brucei: partitioning of reaction intermediates in D2O and activation by phosphite dianion.

Authors:  M Merced Malabanan; Maybelle K Go; Tina L Amyes; John P Richard
Journal:  Biochemistry       Date:  2011-06-06       Impact factor: 3.162

3.  A novel inhibitor of Mammalian triosephosphate isomerase found by an in silico approach.

Authors:  Lorraine Marsh; Kaushal Shah
Journal:  Int J Med Chem       Date:  2014-03-23

Review 4.  The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.

Authors:  Ifedayo Victor Ogungbe; William N Setzer
Journal:  Molecules       Date:  2016-10-19       Impact factor: 4.411

5.  Substrate-Induced Dimerization of Engineered Monomeric Variants of Triosephosphate Isomerase from Trichomonas vaginalis.

Authors:  Samuel Lara-Gonzalez; Priscilla Estrella; Carmen Portillo; María E Cruces; Pedro Jimenez-Sandoval; Juliana Fattori; Ana C Migliorini-Figueira; Marisol Lopez-Hidalgo; Corina Diaz-Quezada; Margarita Lopez-Castillo; Carlos H Trasviña-Arenas; Eugenia Sanchez-Sandoval; Armando Gómez-Puyou; Jaime Ortega-Lopez; Rossana Arroyo; Claudia G Benítez-Cardoza; Luis G Brieba
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.